JP2023541475A5 - - Google Patents

Info

Publication number
JP2023541475A5
JP2023541475A5 JP2023517751A JP2023517751A JP2023541475A5 JP 2023541475 A5 JP2023541475 A5 JP 2023541475A5 JP 2023517751 A JP2023517751 A JP 2023517751A JP 2023517751 A JP2023517751 A JP 2023517751A JP 2023541475 A5 JP2023541475 A5 JP 2023541475A5
Authority
JP
Japan
Application number
JP2023517751A
Other languages
Japanese (ja)
Other versions
JP2023541475A (ja
JPWO2022058902A5 (https=
JP7771172B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2021/058398 external-priority patent/WO2022058902A1/en
Publication of JP2023541475A publication Critical patent/JP2023541475A/ja
Publication of JP2023541475A5 publication Critical patent/JP2023541475A5/ja
Publication of JPWO2022058902A5 publication Critical patent/JPWO2022058902A5/ja
Priority to JP2025186205A priority Critical patent/JP2026041723A/ja
Application granted granted Critical
Publication of JP7771172B2 publication Critical patent/JP7771172B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023517751A 2020-09-17 2021-09-15 Sppl2a阻害剤としての化合物及び組成物 Active JP7771172B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025186205A JP2026041723A (ja) 2020-09-17 2025-11-05 Sppl2a阻害剤としての化合物及び組成物

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063079604P 2020-09-17 2020-09-17
US63/079,604 2020-09-17
PCT/IB2021/058398 WO2022058902A1 (en) 2020-09-17 2021-09-15 Compounds and compositions as sppl2a inhibitors

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025186205A Division JP2026041723A (ja) 2020-09-17 2025-11-05 Sppl2a阻害剤としての化合物及び組成物

Publications (4)

Publication Number Publication Date
JP2023541475A JP2023541475A (ja) 2023-10-02
JP2023541475A5 true JP2023541475A5 (https=) 2024-09-03
JPWO2022058902A5 JPWO2022058902A5 (https=) 2024-09-03
JP7771172B2 JP7771172B2 (ja) 2025-11-17

Family

ID=77897680

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2023517751A Active JP7771172B2 (ja) 2020-09-17 2021-09-15 Sppl2a阻害剤としての化合物及び組成物
JP2025186205A Pending JP2026041723A (ja) 2020-09-17 2025-11-05 Sppl2a阻害剤としての化合物及び組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025186205A Pending JP2026041723A (ja) 2020-09-17 2025-11-05 Sppl2a阻害剤としての化合物及び組成物

Country Status (30)

Country Link
US (1) US20230365571A1 (https=)
EP (2) EP4578451A3 (https=)
JP (2) JP7771172B2 (https=)
KR (1) KR20230069947A (https=)
AU (1) AU2021342783A1 (https=)
CA (1) CA3192763A1 (https=)
CL (2) CL2023000728A1 (https=)
CO (1) CO2023004646A2 (https=)
CR (1) CR20230142A (https=)
DK (1) DK4214210T3 (https=)
DO (1) DOP2023000055A (https=)
EC (1) ECSP23027092A (https=)
ES (1) ES3028668T3 (https=)
FI (1) FI4214210T3 (https=)
GE (2) GEAP202516217A (https=)
HR (1) HRP20250562T1 (https=)
HU (1) HUE071569T2 (https=)
IL (1) IL300953B1 (https=)
JO (1) JOP20230044A1 (https=)
LT (1) LT4214210T (https=)
MA (1) MA61557B1 (https=)
MD (1) MD4214210T2 (https=)
MX (1) MX2023003122A (https=)
PE (1) PE20231099A1 (https=)
PL (1) PL4214210T3 (https=)
PT (1) PT4214210T (https=)
RS (1) RS66874B1 (https=)
SI (1) SI4214210T1 (https=)
SM (1) SMT202500216T1 (https=)
WO (1) WO2022058902A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116947813A (zh) * 2023-07-06 2023-10-27 绍兴贝斯美化工股份有限公司 一种3-氯-4-氨基-1-(3-吡啶基)-1h-吡唑的制备方法
US20250263416A1 (en) 2024-02-15 2025-08-21 Incyte Corporation SPPL2a INHIBITORS

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2124503C1 (ru) * 1992-05-18 1999-01-10 И.Р.Сквибб энд Санз, Инк. Гетероциклические азотсодержащие производные карбоновой кислоты, способ их получения и фармацевтическая композиция
GB9612622D0 (en) 1996-06-17 1996-08-21 Zeneca Ltd Chemical process
US6432944B1 (en) 2000-07-06 2002-08-13 Bristol-Myers Squibb Company Benzodiazepinone β-amyloid inhibitors: arylacetamidoalanyl derivatives
WO2004078163A2 (en) 2003-02-28 2004-09-16 Transform Pharmaceuticals, Inc. Pharmaceutical co-crystal compositions of drugs such as carbamazepine, celecoxib, olanzapine, itraconazole, topiramate, modafinil, 5-fluorouracil, hydrochlorothiazide, acetaminophen, aspirin, flurbiprofen, phenytoin and ibuprofen
EP1773348A4 (en) 2004-07-12 2009-05-20 Idun Pharmaceuticals Inc TETRA PEPTIDE ANALOGS
JP2008545780A (ja) 2005-06-08 2008-12-18 ノバルティス アクチエンゲゼルシャフト 有機化合物
WO2015160772A1 (en) 2014-04-15 2015-10-22 Janssen Pharmaceutica Nv Tetrahydro-benzoimidazolyl modulators of tgr5

Similar Documents

Publication Publication Date Title
BR112023005462A2 (https=)
BR112021014123A2 (https=)
BR112023009656A2 (https=)
BR112022009896A2 (https=)
BR112021017747A2 (https=)
BR112022024743A2 (https=)
BR112022026905A2 (https=)
BR112023011738A2 (https=)
BR112023004146A2 (https=)
BR112023006729A2 (https=)
BR102021018859A2 (https=)
BR102021015500A2 (https=)
BR102021007058A2 (https=)
BR102020022030A2 (https=)
BR112023016292A2 (https=)
BR112023011539A2 (https=)
BR112023011610A2 (https=)
BR112023008976A2 (https=)
BR102021020147A2 (https=)
BR102021018926A2 (https=)
BR102021018167A2 (https=)
BR102021017576A2 (https=)
BR102021016837A2 (https=)
BR102021016551A2 (https=)
BR102021016375A2 (https=)